Image

Molecular Mechanisms Underlying Hip and Knee Osteoarthritis in Patients Undergoing Primary Elective Arthroplasty

Molecular Mechanisms Underlying Hip and Knee Osteoarthritis in Patients Undergoing Primary Elective Arthroplasty

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The aim of this observational study is to determine content of rare metals and other elements, along with the levels of selected immunological parameters, in the tissue of the hip or knee joint in the course of degenerative diseases. Determining potential disturbances in the levels or functions of these parameters may in the future contribute to improving treatment - for example, through supplementation of deficient metals or modulation at the immunological level. The main question it aims to answer is:

Are selected rare metals, trace elements and other selected immunological parameters lowered in the tissue of the hip or knee joint as well as in serum in the course of osteoarthritis?

Eligibility

Inclusion Criteria:

  • 18 years old and more
  • patient qualified for primary TKA or primary THA
  • patient diagnosed with hip or knee osteoarthritis
  • a complete set of tissues of good quality and volume is available
  • does not meet the exclusion criteria.

Exclusion Criteria:

  • lack of written consent to participate in the study or surgery
  • any private or professional relationship with the Investigators
  • genetic connective tissue diseases (e.g., Ehlers-Danlos syndrome and others)
  • genetic metabolic diseases (e.g., gout and others)
  • genetic diseases affecting the anatomy of the operated joint (e.g., dysplasia and others)
  • previous surgeries altering the anatomy of the examined joint (e.g., periacetabular osteotomy, unicompartmental endoprosthesis, and others)
  • patients undergoing revision after THA/TKA
  • autoimmune diseases in the patient's medical history
  • traumatic injury to the hip or knee joint
  • previous participation in the study.

Study details
    Total Hip Arthroplasty (THA)
    Total Knee Arthroplasty (TKA)
    Hip Osteoarthritis
    Knee Osteoarthristis

NCT07347821

Medical University of Warsaw

1 February 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.